Citations

Showing 10 of 108104 citations.

Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia
Epstein‐Peterson, Zachary D. , Derkach, Andriy , Geyer, Susan M. , Mrózek, Krzysztof , Kohlschmidt, Jessica, Park, Jae H. , Rajeeve, Sridevi , Stein, Eytan M. , Zhang, Yanming , Iland, Harry , Campbell, Lynda J. , Powell, Bayard L., Stone, Richard M. , Tallman, Martin S. , Larson, Richard A , Derkach, Andriy , Larson, Richard A. , Poiré, Xavier , Stock, Wendy

Mayo Clinic

Blood Advances | March 29, 2022 | Volume: 6 | Issue: 11 | Pages: 3433-3439

10.1182/bloodadvances.2021006682 | PMID 35349669 Get It

AbstractFrontline arsenic trioxide (ATO)–based treatment regimens achieve high rates of long-term relapse-free survival in treating acute promyelocytic leukemia (APL) and form the current standard of care. Refining prognostic estimates for newly diagnosed patients treated with ATO-containing regimens remains important in continuing to improve outcomes and identify patients who achieve suboptimal outcomes. We performed a pooled analysis of exclusively ATO-treated patients at a single academic institution and from the ALLG APML4 and Alliance C9710 studies to determine the prognostic importance of additional cytogenetic abnormalities and/or complex karyotype. We demonstrated inferior event-free survival for patients harboring complex karyotype (hazard ratio [HR], 3.74; 95% confidence interval [CI], 1.63-8.56; P = .002), but not for patients harboring additional cytogenetic abnormalities (HR, 2.13; 95% CI, 0.78-5.82; P = .142). These data support a role for full karyotypic analysis of all patients with APL and indicate a need for novel treatment strategies to overcome the adverse effect of APL harboring complex karyotype.
The Assessment of Endovascular Therapies in Ischemic Stroke: Management, Problems and Future Approaches
Popiela, Tadeusz , Krzyściak, Wirginia , Pilato, Fabio , Ligezka, Anna N. , Bystrowska, Beata , Bukowska-Straková, Karolina , Brzegowy, Paweł, Kozicz, Tamás , Popiela, Tadeusz J , Ligęzka, Anna , Kozicz, Tamas , Muthusamy, Karthik

Mayo Clinic

Journal of Clinical Medicine | March 29, 2022 | Volume: 11 | Issue: 7 | Pages: 1864

10.3390/jcm11071864 | PMID 35407472 Get It

Ischemic stroke accounts for over 80% of all strokes and is one of the leading causes of mortality and permanent disability worldwide. Intravenous administration of recombinant tissue plasminogen activator (rt-PA) is an approved treatment strategy for acute ischemic stroke of large arteries within 4.5 h of onset, and mechanical thrombectomy can be used for large arteries occlusion up to 24 h after onset. Improving diagnostic work up for acute treatment, reducing onset-to-needle time and urgent radiological access angiographic CT images (angioCT) and Magnetic Resonance Imaging (MRI) are real problems for many healthcare systems, which limits the number of patients with good prognosis in real world compared to the results of randomized controlled trials. The applied endovascular procedures demonstrated high efficacy, but some cellular mechanisms, following reperfusion, are still unknown. Changes in the morphology and function of mitochondria associated with reperfusion and ischemia-reperfusion neuronal death are still understudied research fields. Moreover, future research is needed to elucidate the relationship between continuously refined imaging techniques and the variable structure or physical properties of the clot along with vascular permeability and the pleiotropism of ischemic reperfusion lesions in the penumbra, in order to define targeted preventive procedures promoting long-term health benefits.
Primary Lymphocutaneous Nocardia brasiliensis in an Immunocompetent Host: Case Report and Literature Review
Dumic, Igor , Brown, Alethea, Magee, Kyle, Elwasila, Sammer M , Kaljevic, Marija , Antic, Marina , Igandan, Oladapo, Cardozo, Milena , Prada, Libardo Rueda , Elwasila, Sammer, Rueda Prada, Libardo , Paulson, Margaret, Dumic, Igor , Cardozo, Milena , Paulson, Margaret R.

Mayo Clinic

Medicina | March 29, 2022 | Volume: 58 | Issue: 4 | Pages: 488

10.3390/medicina58040488 | PMID 35454327 Get It

Nocardia spp. is a Gram-positive, partially acid-fast aerobic bacterium usually associated with infection in immunocompromised people. The most common sites of infection are the skin, lungs, and the brain, however disease can disseminate and affect every organ. Clinical manifestations of cutaneous disease are varied and frequently misdiagnosed. We present a case of an immunocompetent 66-year-old man who sustained a left finger injury while gardening. He was misdiagnosed on several occasions and treated with inappropriate antibiotics against Streptococcus spp. and Staphylococcus spp. When infection spread cutaneously, sporotrichoid (lymphocutaneous) nocardiosis was suspected and the patient was started on appropriate therapy with Bactrim which resulted in a cure. We also summarize the literature on lymphocutaneous infection by Nocardia brasiliensis. By reporting this case, we want to raise awareness among clinicians about unusual causes of cellulitis, the differential diagnosis of lymphocutaneous infection and the importance of obtaining a detailed exposure history to assist in the prompt diagnosis of nocardiosis.
Quality of Life and its Determinants in Patients With Adrenal Insufficiency: A Survey Study at 3 Centers in the United States
Li, Dingfeng , Hamidi, Oksana , Westfall, Ashleigh A, Suresh, Malavika, Else, Tobias , Vaidya, Anand , Hamidi, Oksana , Else, Tobias , Bancos, Irina , Brand, Sarah, Westfall, Ashleigh, Bancos, Irina

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | March 29, 2022 | Volume: 107 | Issue: 7 | Pages: e2851-e2861

10.1210/clinem/dgac175 | PMID 35350067 Get It

Abstract Context Current evidence on determinants of quality of life (QoL) in patients with adrenal insufficiency (AI) is limited. Objective This work aimed to identify the determinants of QoL in different subtypes of AI. Methods This multicenter cross-sectional survey study was conducted using a patient-centered questionnaire, the Short Form-36. Results Of 529 participants, 223 (42.2%) had primary AI, 190 (35.9%) had secondary AI, and 116 (21.9%) had glucocorticoid-induced AI. Median age was 58 years (interquartile range: 43-68 years) and 342 (64.8%) were women. In multivariable analyses, patients were more likely to report worse physical scores if they were women (odds ratio [OR]: 3.3; 95% CI, 1.8-6.0), had secondary AI or glucocorticoid-induced AI (OR: 2.5; 95% CI, 1.4-4.3), had shorter duration of AI (OR: 2.0; 95% CI, 1.1-3.6), were treated with more than 25 mg hydrocortisone equivalent daily (OR: 2.3; 95% CI, 1.2-4.6), had more comorbidities related to glucocorticoid excess (OR: 2.3; 95% CI, 1.3-4.0), reported a higher financial burden from AI (OR: 2.1; 95% CI, 1.3-3.6), and reported difficulties with AI management (OR: 2.5; 95% CI, 1.2-5.2). Women (OR: 2.1; 95% CI, 1.08-4.0), shorter duration of AI (OR: 2.4; 95% CI, 1.4-4.3), higher financial burden (OR: 2.3; 95% CI, 1.3-4.0), difficulties with AI management (OR: 2.6; 95% CI, 1.4-4.9), and lack of family support (OR: 9.1; 95% CI, 2.3-33.3) were associated with worse mental component scores. Conclusion In patients with AI, QoL could be improved by addressing certain determinants, such as avoiding GC overreplacement, providing in-depth education on self-management, offering more comprehensive insurance coverage, and ensuring better family support.
Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor–Positive Breast Cancer
Abubakar, Mustapha , Mullooly, Maeve , Nyante, Sarah J. , Pfeiffer, Ruth M. , Bowles, Erin J. Aiello , Cora, Renata , Bodelón, Clara , Butler, Eboneé N. , Butcher, Donna , Sternberg, Lawrence, Weinmann, Sheila , Glass, Andrew G., González, Amy Berrington de , Gierach, Gretchen L. , Nyante, Sarah , Aiello Bowles, Erin J , Butler, Eboneé , Sherman, Mark , Berrington de Gonzalez, Amy , Gierach, Gretchen L , Pfeiffer, Ruth M , Troester, Melissa A. , Sherman, Mark E.

Mayo Clinic

JNCI Cancer Spectrum | March 29, 2022 | Volume: 6 | Issue: 3 | Pages: No page available

10.1093/jncics/pkac028 | PMID 35583138 Get It

Abstract Background Mammographic breast density (MBD) decline post-tamoxifen initiation is a favorable prognostic factor in estrogen receptor (ER)–positive breast cancer (BC) and has potential utility as a biomarker of tamoxifen response. However, the prognostic value of MBD decline may vary by molecular characteristics among ER–positive patients. Methods We investigated associations between MBD decline (≥10% vs <10%) and breast cancer–specific mortality (BCSM) among ER–positive breast cancer patients aged 36-87 years at diagnosis treated with tamoxifen at Kaiser Permanente Northwest (1990-2008). Patients who died of BC (case patients; n = 62) were compared with those who did not (control patients; n = 215) overall and by tumor molecular characteristics (immunohistochemistry [IHC]–based subtype [luminal A–like: ER–positive/progesterone receptor [PR]–positive/HER2–negative/low Ki67; luminal B–like: ER–positive and 1 or more of PR–negative, HER2–positive, high Ki67] and modified IHC [mIHC]–based recurrence score of ER/PR/Ki67). Percent MBD was measured in the unaffected breast at baseline mammogram (mean = 6 months before tamoxifen initiation) and follow-up (mean = 12 months post-tamoxifen initiation). Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were computed from logistic regression models. All statistical tests were 2-sided. Results MBD decline was statistically significantly associated with reduced risk of BCSM overall (OR = 0.38, 95% CI = 0.15 to 0.92). This association was, however, stronger among women with aggressive tumor characteristics including luminal B–like (OR = 0.17, 95% CI = 0.04 to 0.73) vs A–like (OR = 0.74, 95% CI = 0.19 to 2.92); large (OR = 0.26, 95% CI = 0.08 to 0.78) vs small (OR = 0.41, 95% CI = 0.04 to 3.79) tumors; PR–negative (OR = 0.02, 95% CI = 0.001 to 0.37) vs PR–positive (OR = 0.50, 95% CI = 0.18 to 1.40) disease; and high (OR = 0.25, 95% CI = 0.07 to 0.93) vs low (OR = 0.44, 95% CI = 0.10 to 2.09) mIHC3 score. Conclusion The findings support MBD decline as a prognostic marker of tamoxifen response among patients with aggressive ER–positive BC phenotypes, for whom understanding treatment effectiveness is critical.
Local Infiltration of Tranexamic Acid During Facelift Improves Operating Room Efficiency: A Matched Patient Study
Coombs, Demetrius M. , Kwiecień, Grzegorz , Sinclair, Nicholas R , Jin, Alison , Zins, James E. , Kwiecien, Grzegorz J

Mayo Clinic

Aesthetic Surgery Journal | March 29, 2022 | Volume: 42 | Issue: 9 | Pages: 971-977

10.1093/asj/sjac067 | PMID 35350068 Get It

Abstract Background Tranexamic acid (TXA) has rapidly gained popularity in aesthetic surgery. Previous reports have suggested that TXA provides a dry surgical field and significantly reduces operating time during facelift surgery. Objectives The aim of this study was to build upon earlier findings by providing a large cohort matched alongside historic controls and more clearly document time saved when performing facelift surgery. Methods A retrospective, single-surgeon case-control study was undertaken between July 2016 and October 2021. All patients underwent facelift surgery alone or in combination with fat transfer and perioral chemical peel. All patients received subcutaneous infiltration of 0.5% lidocaine/1:200,000 epinephrine with or without 1 or 2 mg/mL TXA. Patient demographics, TXA dose, surgical time, and minor and major complications were examined. Results In total 145 consecutive patients were identified: 73 in Group 1 (no-TXA) and 72 in Group 2 (TXA). No differences in terms of gender distribution (P = 0.75), age (P = 0.54), BMI (P = 0.18), frequency of secondary rhytidectomy (P = 0.08), rate of ancillary lipografting (P = 0.44), TXA dose (P = 0.238), and minor complication rate (P = 0.56) were observed. However, mean surgical time in the no-TXA group was 21 minutes longer than in the TXA group (P = 0.016). Six patients (8%) in the no-TXA group experienced minor complications vs 8 patients (11%) in the TXA group. No patients experienced major complications. Conclusions Although previous studies have highlighted the potential benefits of TXA in aesthetic surgery, most of the data remain subjective and non-validated. This report adds to the objective body of evidence supporting TXA in facial aesthetic surgery by documenting time saved in the operating room without additional surgical morbidity. Level of Evidence: 4
Acquired Immunotherapy Resistance in Gastrointestinal Cancers
Zhu, Mojun , Bekaii‐Saab, Tanios , Bekaii-Saab, Tanios S

Mayo Clinic

JAMA Network Open | March 29, 2022 | Volume: 5 | Issue: 3 | Pages: e224646

10.1001/jamanetworkopen.2022.4646 | PMID 35348714 Get It

Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes
Lee, Sung Hwan , Yim, Sun Young , Jeong, Yun Seong , Li, Qi‐Xiang, Kang, Sanghee , Sohn, Bo Hwa, Kumar, Shwetha V. , Shin, Ji‐Hyun , Choi, You Rhee, Kim, Hayeon , Kim, Ji Hoon , Kim, Shin , Guo, Sheng , Johnson, Randy L. , Kang, Koo Jeong , Chun, Yun Shin , Jang, Hee Jin, Lee, Byoung Gill, Woo, Hyun Goo , Akbani, Rehan , Roberts, Lewis R. , Wheeler, David A. , Kang, Sang-Hee , Kim, Ji Hoon , Ha, Min Jin , Roberts, Lewis R , Shim, Jae‐Jun , Kaseb, Ahmed O , Lee, Ju‐Seog

Mayo Clinic

Hepatology | March 29, 2022 | Volume: 76 | Issue: 6 | Pages: 1634-1648

10.1002/hep.32490 | PMID 35349735 Get It

Abstract Background and Aims Although many studies revealed transcriptomic subtypes of HCC, concordance of the subtypes are not fully examined. We aim to examine a consensus of transcriptomic subtypes and correlate them with clinical outcomes. Approach and Results By integrating 16 previously established genomic signatures for HCC subtypes, we identified five clinically and molecularly distinct consensus subtypes. STM (STeM) is characterized by high stem cell features, vascular invasion, and poor prognosis. CIN (Chromosomal INstability) has moderate stem cell features, but high genomic instability and low immune activity. IMH (IMmune High) is characterized by high immune activity. BCM (Beta‐Catenin with high Male predominance) is characterized by prominent β‐catenin activation, low miRNA expression, hypomethylation, and high sensitivity to sorafenib. DLP (Differentiated and Low Proliferation) is differentiated with high hepatocyte nuclear factor 4A activity. We also developed and validated a robust predictor of consensus subtype with 100 genes and demonstrated that five subtypes were well conserved in patient‐derived xenograft models and cell lines. By analyzing serum proteomic data from the same patients, we further identified potential serum biomarkers that can stratify patients into subtypes. Conclusions Five HCC subtypes are correlated with genomic phenotypes and clinical outcomes and highly conserved in preclinical models, providing a framework for selecting the most appropriate models for preclinical studies.
Association Between Race and Opioid-Induced Respiratory Depression: An International Post Hoc Analysis of the Prediction of Opioid-induced Respiratory Depression In Patients Monitored by Capnography Trial
Sim, Ming Ann, Seet, Edwin, Khanna, Ashish K., Weingarten, Toby N., Liew, Lydia, Law, Lawrence Siu-Chun, Liu, Katherine E., Piazza, Fabio Di, Ti, Lian Kah, Investigators, on behalf of the PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY) Group, Wittmann, Mária , Sim, Ming Ann, Seet, Edwin, Khanna, Ashish K., Weingarten, Toby N., Liew, Lydia, Law, Lawrence Siu‐Chun , Liu, Katherine E., Piazza, Fabio Di, Ti, Lian Kah, Investigators, on behalf of the PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY) Group

Mayo Clinic

Anesthesia & Analgesia | March 29, 2022 | Volume: 135 | Issue: 5 | Pages: 1097-1105

10.1213/ane.0000000000006006 | PMID 35350054 Get It

BACKGROUND: Opioid-induced respiratory depression (OIRD) is common on the medical and surgical wards and is associated with increased morbidity and health care costs. While previous studies have investigated risk factors for OIRD, the role of race remains unclear. We aim to investigate the association between race and OIRD occurrence on the medical/surgical ward. METHODS: This is a post hoc analysis of the PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY) trial; a prospective multinational observational blinded study of 1335 general ward patients who received parenteral opioids and underwent blinded capnography and oximetry monitoring to identify OIRD episodes. For this study, demographic and perioperative data, including race and comorbidities, were analyzed and assessed for potential associations with OIRD. Univariable χ 2 and Mann-Whitney U tests were used. Stepwise selection of all baseline and demographic characteristics was used in the multivariable logistic regression analysis. RESULTS: A total of 1253 patients had sufficient racial data (317 Asian, 158 Black, 736 White, and 42 other races) for inclusion. The incidence of OIRD was 60% in Asians (N = 190/317), 25% in Blacks (N = 40/158), 43% in Whites (N = 316/736), and 45% (N = 19/42) in other races. Baseline characteristics varied significantly: Asians were older, more opioid naïve, and had higher opioid requirements, while Blacks had higher incidences of heart failure, obesity, and smoking. Stepwise multivariable logistic regression revealed that Asians had increased risk of OIRD compared to Blacks (odds ratio [OR], 2.49; 95% confidence interval [CI], 1.54–4.04; P = .0002) and Whites (OR, 1.38; 95% CI, 1.01–1.87; P = .0432). Whites had a higher risk of OIRD compared to Blacks (OR, 1.81; 95% CI, 1.18–2.78; P = .0067). The model’s area under the curve was 0.760 (95% CI, 0.733–0.787), with a Hosmer-Lemeshow goodness-of-fit test P value of .23. CONCLUSIONS: This post hoc analysis of PRODIGY found a novel association between Asian race and increased OIRD incidence. Further study is required to elucidate its underlying mechanisms and develop targeted care pathways to reduce OIRD in susceptible populations.
International percutaneous coronary intervention complication survey
Kostantinis, Spyridon , Karácsonyi, Judit , Hall, Allison B. , Rangan, Bavana V. , Croce, Kevin , Azzalini, Lorenzo , McEntegart, Margaret , Shishehbor, Mehdi H. , Egred, Mohaned , Mastrodemos, Olga , Sorajja, Paul , Lombardi, William, Sandoval, Yader , Simsek, Bahadir , Kostantinis, Spyridon , Hall, Allison , Azzalini, Lorenzo , Egred, Mohaned , Sorajja, Paul , Banerjee, Subhash , Brilakis, Emmanouil S.

Mayo Clinic

Catheterization and Cardiovascular Interventions | March 29, 2022 | Volume: 99 | Issue: 6 | Pages: 1733-1740

10.1002/ccd.30173 | PMID 35349771 Get It

AbstractObjectivesTo investigate the perceptions of interventional cardiologists (IC) regarding the frequency, impact, and management strategies of percutaneous coronary intervention (PCI) complications.BackgroundThe perceptions and management strategies of ICs of PCI complications have received limited study.MethodsOnline survey on PCI complications: 46 questions were distributed via email lists and Twitter to ICs.ResultsOf 11,663 contacts, 821 responded (7% response rate): 60% were from the United States and the median age was 46–50 years. Annual PCI case numbers were <100 (26%), 100–199 (37%), 200–299 (21%), and ≥300 (16%); 42% do not perform structural interventions, others reported performing <40 (30%), or >100 (11%) structural cases annually. On a scale of 0–10, participating ICs were highly concerned about potential complications with a median score of 7.2 (interquartile range: 5.0–8.7). The most feared complication was death (39%), followed by coronary perforation (26%) and stroke (9%). Covered stents were never deployed by 21%, and 32% deployed at least one during the past year; 79% have never used fat to seal perforations; 64% have never used coils for perforations. Complications were attributed to higher patient/angiographic complexity by 68% and seen as opportunities for improvement by 70%; 97% of participants were interested in learning more about the management of PCI complications. The most useful learning methods were meetings (66%), webinars (48%), YouTube (32%), and Twitter (29%).ConclusionICs who participated in the survey are highly concerned about complications. Following complication management algorithms and having access to more experienced operators might alleviate stress and optimize patient outcomes.